<- Go Home

Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally.

Market Cap

$1.6B

Volume

44.8K

Cash and Equivalents

$362.9M

EBITDA

$38.4M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$305.0M

Profit Margin

48.47%

52 Week High

$45.76

52 Week Low

$32.67

Dividend

N/A

Price / Book Value

0.90

Price / Earnings

29.98

Price / Tangible Book Value

0.91

Enterprise Value

$277.7M

Enterprise Value / EBITDA

7.23

Operating Income

$7.3M

Return on Equity

3.06%

Return on Assets

0.21

Cash and Short Term Investments

$879.4M

Debt

N/A

Equity

$1.8B

Revenue

$629.2M

Unlevered FCF

$21.0M

Sector

Pharmaceuticals

Category

N/A

Company Stock Pitches